제이투케이바이오

420570KOSDAQ기타 화학제품 제조업

58.3 / 100

Reference Date: 2026-06-10

Financial Score24.0 / 40

News Sentiment21.3 / 25

Momentum3.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but Operating Profit is on a declining trend. Declined 7.6% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

JtK Bio, established in 2017, is a company specializing in the development and sales of cosmetic raw materials based on natural substances and fermented microorganisms. It operates two main business segments: cosmetic material production (including natural, bio, and solvent-based materials) and clinical services (such as efficacy evaluation through human trials).

Number of Employees

59people

Average Salary

56.2M KRW

Score Calculation Basis

Detailed Financial Score

PER

15.84Industry Average 16.505.0Point

In line with industry avg

PBR

1.26Industry Average 1.132.5Point

Higher than industry avg (caution)

ROE

8.21Industry Average 4.555.5Point

1.8x industry avg (good)

Debt Ratio

3.55Industry Average 8.136.5Point

Half of industry avg (excellent)

Trend 2023~20254.5 / 10 points

Revenue Growth Rate

2.0 / 3

Avg ▲7.9% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼27.4% (2-year basis)

ROE Trend

2.5 / 4

Avg ROE 11.6% (declining, 3yr)

Detailed News Sentiment

2 totalPositive 2Neutral 0Negative 0Average Sentiment Score 85

Positive
제이투케이바이오, 1분기 영업이익 19억…전년比 476.6%↑
제이투케이바이오의 1분기 영업이익이 전년 대비 대폭 증가하여 긍정적인 실적을 보여주고 있다.
Positive
제이투케이바이오, 1Q 영업익 476% 급증…"K뷰티 수혜 본격화"
제이투케이바이오의 1분기 영업이익이 전년 동기 대비 476% 급증하며 K뷰티 관련 수혜가 본격화되고 있다.

Detailed Momentum

52-week position1.0Point

Near 52w low (1%, downtrend)

Current 7,270Won52-week high 11,20052-week low 7,210

1-month return1.0Point

1m -7.62% (falling)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0

Neutral분기보고서 (2026.03)2026-05-14
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-12